brinzolamide

Known as: (R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-e)-1,2-thiazine-6-sulfonamide, brinzolamide [Chemical/Ingredient] 
A sulfonamide and carbonic anhydrase inhibitor with specific affinity for carbonic anhydrase II. Following topical ocular administration… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2018
0102019982018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
IMPORTANCE This study evaluates the contribution of the individual components of an investigational non-β-antagonist fixed… (More)
Is this relevant?
2008
2008
AIMS To assess the effects of brinzolamide and dorzolamide on ocular haemodynamics and retinal oxygen saturation in patients with… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
OBJECTIVE To estimate the intraocular pressure (IOP) reduction achieved by the most frequently prescribed glaucoma drugs and a… (More)
Is this relevant?
2004
2004
AIM A prospective, randomised study to evaluate effects of brinzolamide on ocular haemodynamics in healthy volunteers. METHODS… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2001
2001
PURPOSE The aim was to compare topical brinzolamide 1% twice daily with dorzolamide 2% twice daily, each given with timolol 0.5… (More)
Is this relevant?
2000
2000
BACKGROUND The first topically active carbonic anhydrase inhibitor, dorzolamide, was developed to circumvent the adverse systemic… (More)
Is this relevant?
2000
2000
A randomized, multicenter, double-masked, prospective, parallel study was designed to establish the intraocular pressure (IOP… (More)
Is this relevant?
2000
2000
Two independent, prospective, multicenter, double-masked, parallel group trials were conducted to compare the ocular comfort of… (More)
Is this relevant?
1998
1998
PURPOSE To determine the intraocular pressure-lowering efficacy and safety of brinzolamide 1.0%, compared with dorzolamide 2.0… (More)
Is this relevant?